Endogenous IGF-1 is suppressed during use (Tomas et al., 1997) and recovers across the off-period
Consistent with these findings, the current study confirmed that the semaglutide-intensified treatment group exhibited reduced fasting plasma glucose, fasting insulin, total cholesterol, triglyceride, and LDL-C levels compared with baseline
For patients with severe obesity (BMI 40 kg/m or 35 kg/m with comorbidities) who have not achieved adequate weight loss with non-surgical interventions, bariatric surgery may be considered following specialist assessment, as outlined in NICE CG189
Eligible participants were 18 years or older and had type 2 diabetes treated with a combination of metformin, sulfonylurea, or sodium-glucose co-transporter-2 inhibitor
In a supervised protocol your provider confirms your exact dose, timing, and cycle after reviewing your labs